Trial Search Results

MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery

To see if performing breast MRI before a lumpectomy will help the surgeon successfully remove the entire cancer with normal tissue margins in a single operation thereby reducing the need for additional surgical procedures. The study will also measure how well MRI can find unsuspected cancers in the same breast as the known cancer; how well MRI will find unsuspected cancers in the opposite breast; how often MRI will generate false positive MRI findings; whether routinely incorporating breast MRI delays care or adds unnecessary cost; and, whether breast MRI is able to reduce the frequency of cancer recurrence in the treated breast or elsewhere in the body.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: Breast MRI

Phase:

Phase 3

Eligibility


Inclusion Criteria:

   - DCIS less than 5 cm. T1/T2 invasive breast cancer. Patient is a suitable candidate for
   breast conservation and wishes this as the primary clinical approach

   - No breast MRI within the past year. Prior core biopsy, but no prior excision allowed.
   Patient has completed conventional imaging workup with mammography ultrasound as
   indicated and there is no clinical indication for breast MRI.

   - Women with age >= 18. No ethnic restrictions.

   - No life expectancy restrictions.

   - Performance status not a factor.

   - No requirements for organ or marrow function.

   - Ability to understand and the willingness to sign a written informed consent
   document.

Exclusion Criteria:

   - Patient is unable to complete a breast MRI due to such factors as hardware and
   claustrophobia.

   - No limitations as to other investigational agents. Patients who have received
   neoadjuvant chemotherapy will not be included in the study due to the limitations of
   MRI interpretation after neoadjuvant chemotherapy and because this represents a
   distinct scenario for interpretation of breast MRI in comparison with untreated
   patients.

   - There are no comorbidities that would preclude entry into the study unless the patient
   is unable to lay still for breast MRI scanning.

   - There are fewer reactions to MRI contrast media, but if there is such a history, the
   patient will be excluded from consideration.

   - There are no exclusion criteria based on concomitant medications.

   - There are no other agent specific exclusion criteria.

   - Pregnancy is considered a contraindication given the uncertain effects of breast MRI
   on the fetus.

   - Cancer survivors are candidates for the study unless the patient has a prior
   ipsilateral breast tumor.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sally Bobo
650-736-1472
Not Recruiting